It's an accelerated approval which allows the company 9 years to conduct a confirmatory study, which isn't particularly strict around timing it seems. Another long term study for CGS, meanwhile Biogen stock up 42% after they priced it at the top end of expectations.
5 Weeks until Aducanumab PDUFA date, page-15
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.030(2.43%) |
Mkt cap ! $216.0M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.27 | $1.24 | $2.93K | 2.366K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18542 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 416 | 1 |
View Market Depth
| Last trade - 12.56pm 26/07/2024 (20 minute delay) ? |
| CGS (ASX) Chart |